Sign inJoin waitlistJoin the waitlist

Banu Arun

Co-Medical Director, Clinical Cancer Genetics · University of Texas M D Anderson Cancer Center

Credentials: · · · ·

History

Clinical Cancer Genetics · University of Texas M D Anderson Cancer Center
Present
University of Texas M D Anderson Cancer Center
Present
University of Texas M D Anderson Cancer Center
Present

Vincent T. Lombardi Cancer Center Georgetown University
1994–1997
University of Istanbul
1990–1994
Doctor of Medicine
1985–1989

Research

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
The Lancet · 2010 · 1,426 citations
Association analysis identifies 65 new breast cancer risk loci
Nature · 2017 · 1,113 citations
Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human…
Journal of Clinical Oncology · 2005 · 895 citations

Jennifer Litton
66 papers · 1 as a fellow
Gabriel Hortobagyi
63 papers
Vicente Valero
56 papers
Susan Domchek
44 papers
Judy Garber
42 papers
Beth Karlan
37 papers
Jeffrey Weitzel
36 papers
KO
Kenneth Offit
36 papers
Nadine Tung
34 papers
Olufunmilayo Olopade
34 papers
Karen Lu
32 papers
Katherine Nathanson
32 papers

Grants

Genetic Risk Prediction in Primary Care
National Cancer Institute · R03
PI · $164.7K · University of Texas Dallas
2013–2016
Biomarker Modulation/COX-2 Inhibitor/Breast Cancer
National Cancer Institute · R03
Contact PI · $151K · University of Tx Md Anderson Can Ctr
2002–2006
An Exploratory Study to Identify Potential Surrogate End
National Cancer Institute · N01
Contact PI · $218.8K · Ut Southwestern Medical Center
1999–2002

Clinical trials

Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics
Principal investigator · Recruiting
M.D. Anderson Cancer Center
2022–2027
Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic Counseling
Principal investigator · Recruiting
M.D. Anderson Cancer Center
2022–2027
Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer
Principal investigator · Recruiting · Phase 2
M.D. Anderson Cancer Center
2020–2027
Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center
2018–2021